BackGlobal Blood Therapeutics Overview

Global Blood Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for GBT.

Quarterly EBIT

-$73.88M
↓ 12.08% YoY

As of Jun 30, 2022

Annual EBIT (TTM)

-$297.39M
↓ 17.25% YoY

Trailing 12 months ending Jun 30, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin